Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Generation Ages Author: Karen Young Kreeger Date: February 19, 1996 As the baby-boomer generation gets older, biotech companies are stepping up their research efforts with the goal of capitalizing on the huge potential market for anti-aging products. The number of drugs and therapies in development for diseases of the elderly increased from 125 in 1993 to 132 in July 1995. The number of companies developing those remedies climbed from 60 to 71 in the same time frame, according to New Medicines